Nutritional needs are 'shifting' amid rise of weight loss drugs, says Nestle CEO
Publishing timestamp: 2024-05-30 05:44:57
Summary
Nestle CEO Mark Schneider discusses the rise of weight loss drugs and how it is changing consumers' nutritional needs. Nestle is launching frozen food products targeted at GLP-1 weight loss drug users called Vital Pursuit. The company sees an opportunity to provide healthier products and companion offerings for consumers on weight loss treatments.
Sentiment: MIXED
Tickers: NES.N-CH,
Keywords: nutrition, weight loss diets, food trends, food science, nestle sa, health care industry, retail industry, food and drink, breaking news: business, business news, dietary supplements, diets and dieting,